EPIX Stock Risk & Deep Value Analysis

ESSA Pharma Inc.

Healthcare • Biotechnology

DVR Score

7.8

out of 10

Solid Pick

The Bottom Line on EPIX

We analyzed ESSA Pharma Inc. using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran EPIX through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Oct 9, 2025•Run Fresh Analysis →

📈EPIX Performance Overview3yr weekly

📊

Unlock EPIX Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close · Quarterly revenue & EPS · DVR score history

About ESSA Pharma Inc. (EPIX)

Sector

Healthcare

Industry

Biotechnology

Market Cap Category

small

Market Cap

$9.52M

EPIX Deep Value Analysis

ESSA Pharma presents a high-risk, high-reward opportunity with its novel AR NTD inhibitor, bavdegalutamide, targeting the significant mCRPC market where patients develop resistance to current therapies. This first-in-class approach offers strong scientific differentiation and a large TAM. Leadership is experienced. However, its 'dud' risk is the inherent binary outcome of clinical trials; failure would lead to total loss and an unsustainable financial trajectory given its significant burn rate and reliance on continuous capital raises for future milestones, despite a recent PIPE. Success offers clear 10x potential.

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

🔥 New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

✓ Catalysts, bull case, moat & red flags
✓ Unlimited stock analyses + alerts
✓ Full database, search & portfolio (50 stocks)

Get Premium — $47/yr

7-day money back · Cancel anytime

EPIX Financial Health Metrics

Market Cap

$9.52M

🔔

Never miss a move on EPIX

Create a free account to set price alerts and get notified on Telegram when EPIX hits your targets.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

FAQ

What is the DVR Score for ESSA Pharma Inc. (EPIX)?

As of October 9, 2025, ESSA Pharma Inc. has a DVR Score of 7.8 out of 10, placing it in the "Solid Pick" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of ESSA Pharma Inc.?

ESSA Pharma Inc.'s market capitalization is approximately $9.5M. The company operates in the Healthcare sector within the Biotechnology industry.

What ticker symbol does ESSA Pharma Inc. use?

EPIX is the ticker symbol for ESSA Pharma Inc.. The company trades on the NCM.

How often is the EPIX DVR analysis updated?

Our AI-powered analysis of ESSA Pharma Inc. is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on October 9, 2025.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.